| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1995;92:2831-2840.)
© 1995 American Heart Association, Inc.
Articles |
A Comparison of the Costs of and Quality of Life After Coronary Angioplasty or Coronary Surgery for Multivessel Coronary Artery Disease
Results From the Emory Angioplasty Versus Surgery Trial (EAST)
Presented in part at the 66th Scientific Sessions of the American Heart Association, Atlanta, Ga, November 8-11, 1993.
From the Division of Cardiology, Department of Medicine, Emory University School of Medicine, and the Division of Health Policy and Management, Emory University School of Public Health, Atlanta, Ga.
Correspondence to William S. Weintraub, MD, Division of Cardiology, Emory University Hospital, 1364 Clifton Rd NE, Atlanta, GA 30322. Email bill@hp3.eushc.org.
Background The Emory Angioplasty Versus Surgery Trial (EAST) is a randomized trial that compares, by intention to treat, the clinical outcome and costs of percutaneous transluminal coronary angioplasty (PTCA) and coronary surgery for multivessel coronary artery disease.
Methods and Results The primary end point was a composite of death, Q-wave myocardial infarction, and a large reversible thallium defect at 3 years. Multiple measures of quality of life also were made. Charges were assessed from the hospital UB-82 bills; professional charges were assessed from the Emory Clinic. Hospital charges were reduced to cost through step-down accounting methods. All costs and charges were deflated to 1987 dollars. Costs were assessed for the initial hospitalization and the cumulative costs of the initial hospitalization and additional revascularization procedures for up to 3 years. There was no difference in mortality or the primary end point. Mean initial hospital charges were $12 654 for the PTCA group and $20 214 for the surgery group (P<.0001). Professional charges were $4538 for PTCA and $9426 for surgery (P<.0001). Three-year hospital charges were $19 047 for PTCA and $21 174 for coronary surgery (P<.0001). Three-year professional charges were $6412 for PTCA and $9861 for surgery (P<.0001). Three-year total charges were $25 458 for PTCA and $31 033 for surgery (P<.0001). Total 3-year costs were $23 734 for PTCA and $25 310 for coronary surgery (P<.0001). There were more hospitalizations for angina and more antianginal medications used in the PTCA group, which would further narrow the differences in cost.
Conclusions There was no difference in the primary end point or its components at 3 years. Although the primary procedural costs of coronary surgery are more than for coronary angioplasty, this cost advantage is largely, although probably not completely, lost by 3 years because of more frequent additional procedures and other resource consumption after a first revascularization by PTCA.
Key Words: coronary disease • angioplasty • cost-benefit analysis
This article has been cited by other articles:
 |
|
 |
|
  D. M. Bravata, A. L. Gienger, K. M. McDonald, V. Sundaram, M. V. Perez, R. Varghese, J. R. Kapoor, R. Ardehali, D. K. Owens, and M. A. Hlatky Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery Ann Intern Med, November 20, 2007; 147(10): 703 - 716. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Shaw, T. H. Marwick, D. S. Berman, S. Sawada, G. V. Heller, C. Vasey, and D. D. Miller Incremental cost-effectiveness of exercise echocardiography vs. SPECT imaging for the evaluation of stable chest pain Eur. Heart J., October 2, 2006; 27(20): 2448 - 2458. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Szygula-Jurkiewicz, M. Zembala, K. Wilczek, R. Wojnicz, and L. Polonski Health related quality of life after percutaneous coronary intervention versus coronary artery bypass graft surgery in patients with acute coronary syndromes without ST-segment elevation. 12-month follow up Eur. J. Cardiothorac. Surg., May 1, 2005; 27(5): 882 - 886. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Schleinitz and P. A. Heidenreich A Cost-Effectiveness Analysis of Combination Antiplatelet Therapy for High-Risk Acute Coronary Syndromes: Clopidogrel plus Aspirin versus Aspirin Alone Ann Intern Med, February 15, 2005; 142(4): 251 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Spertus, R. Nerella, R. Kettlekamp, J. House, S. Marso, A. M. Borkon, and J. S. Rumsfeld Risk of Restenosis and Health Status Outcomes for Patients Undergoing Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft Surgery Circulation, February 15, 2005; 111(6): 768 - 773. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W S Weintraub, E M Mahoney, Z Zhang, H Chu, J Hutton, M Buxton, J Booth, F Nugara, R H Stables, P Dooley, et al. One year comparison of costs of coronary surgery versus percutaneous coronary intervention in the stent or surgery trial Heart, July 1, 2004; 90(7): 782 - 788. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Zhang, E. M. Mahoney, R. H. Stables, J. Booth, F. Nugara, J. A. Spertus, and W. S. Weintraub Disease-Specific Health Status After Stent-Assisted Percutaneous Coronary Intervention and Coronary Artery Bypass Surgery: One-Year Results From the Stent or Surgery Trial Circulation, October 7, 2003; 108(14): 1694 - 1700. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Rumsfeld, D. J. Magid, M. E. Plomondon, J. Sacks, W. Henderson, M. Hlatky, G. Sethi, D. A. Morrison, and Veterans Affairs Angina With Extremely Serious Ope Health-related quality of life after percutaneous coronary intervention versus coronary bypass surgery in high-risk patients with medically refractory ischemia J. Am. Coll. Cardiol., May 21, 2003; 41(10): 1732 - 1738. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. P. Cannon, A. Battler, R. G. Brindis, J. L. Cox, S. G. Ellis, N. R. Every, J. T. Flaherty, R. A. Harrington, H. M. Krumholz, M. L. Simoons, et al. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes: A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee) Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, American College of Emergency Physicians, American Heart Association, Cardiac Society of Australia & New Zealand, National Heart Foundation of Australia, Society for Cardiac Angiography and Interventions, and the Taiwan Society of Cardiology J. Am. Coll. Cardiol., December 1, 2001; 38(7): 2114 - 2130. [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Shaw, A. E. Iskandrian, R. Hachamovitch, G. Germano, H. C. Lewin, T. M. Bateman, and D. S. Berman Evidence-Based Risk Assessment in Noninvasive Imaging J. Nucl. Med., September 1, 2001; 42(9): 1424 - 1436. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Smith Jr, J. T. Dove, A. K. Jacobs, J. Ward Kennedy, D. Kereiakes, M. J. Kern, R. E. Kuntz, J. J. Popma, H. V. Schaff, D. O. Williams, et al. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines): A report of the American College of Cardiology/ American Heart Association Task Force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions J. Am. Coll. Cardiol., June 15, 2001; 37(8): 2239 - 2239. [Full Text] [PDF]
|
|
|
|
 |
|
 E. Simchen, N. Galai, D. Braun, Y. Zitser-Gurevich, E. Shabtai, and I. Naveh Sociodemographic and clinical factors associated with low quality of life one year after coronary bypass operations: The Israeli Coronary Artery Bypass Study (ISCAB) J. Thorac. Cardiovasc. Surg., May 1, 2001; 121(5): 909 - 919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. B. King III, A. S. Kosinski, R. A. Guyton, N. J. Lembo, W. S. Weintraub, and for the Emory Angioplasty Versus Surgery Trial (EA Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST) J. Am. Coll. Cardiol., April 1, 2000; 35(5): 1116 - 1121. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 j. Cross The Economics of Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 1999; 3(4): 227 - 230. [Abstract] [PDF]
|
|
|
|
|
|
W. S. Weintraub, S. Culler, S. J. Boccuzzi, J. R. Cook, A. S. Kosinski, D. J. Cohen, J. Burnette, and for the RESTORE Trial Study Group Economic impact of GPIIB/IIIA blockade after high-risk angioplasty: Results from the restore trial J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1061 - 1066. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Eagle, R. A. Guyton, R. Davidoff, G. A. Ewy, J. Fonger, T. J. Gardner, J. P. Gott, H. C. Herrmann, R. A. Marlow, W. C. Nugent, et al. ACC/AHA guidelines for coronary artery bypass graft surgery: A report of the American College of Cardiology/ American Heart Association task force on Practice Guidelines (Committee to revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery) J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1262 - 1347. [Full Text] [PDF]
|
|
|
|
|
|
T. TREASURE The measurement of health related quality of life Heart, April 1, 1999; 81(4): 331 - 332. [Full Text]
|
|
|
|
|
|
C. R. Cartwright and C. M. Mangano Quality of Life After Coronary Artery Bypass Surgery: Past Progress and Future Directions Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 1998; 2(4): 302 - 310. [Abstract] [PDF]
|
|
|
|
|
|
V. A. Ferraris, S. P. Ferraris, and A. Singh Operative Outcome And Hospital Cost J. Thorac. Cardiovasc. Surg., March 1, 1998; 115(3): 593 - 603. [Abstract] [Full Text]
|
|
|
|
|
|
G. W. Barsness, E. D. Peterson, E. M. Ohman, C. L. Nelson, E. R. DeLong, J. G. Reves, P. K. Smith, R. D. Anderson, R. H. Jones, D. B. Mark, et al. Relationship Between Diabetes Mellitus and Long-term Survival After Coronary Bypass and Angioplasty Circulation, October 21, 1997; 96(8): 2551 - 2556. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. A. Hlatky, W. J. Rogers, I. Johnstone, D. Boothroyd, M. M. Brooks, B. Pitt, G. Reeder, T. Ryan, H. Smith, P. Whitlow, et al. Medical Care Costs and Quality of Life after Randomization to Coronary Angioplasty or Coronary Bypass Surgery N. Engl. J. Med., January 9, 1997; 336(2): 92 - 99. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Simoons Myocardial Revascularization -- Bypass Surgery or Angioplasty? N. Engl. J. Med., July 25, 1996; 335(4): 275 - 277. [Full Text]
|
|
|
|
 |
|
 IS PTCA LESS EXPENSIVE THAN CABG? Journal Watch (General), December 1, 1995; 1995(1201): 6 - 6. [Full Text]
|
|